JOHNSON & JOHNSON |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 134.8 EUR | -1.43% |
|
-0.07% | -3.46% |
| Jul. 03 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
| Jul. 03 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
